Cardiac arrhythmias and overall outcomes with Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia

Stefano H Byer; Aravinthasamy Sivamurugan; Udhayvir S Grewal; Paari Dominic

doi:10.1016/j.hrthm.2024.07.009

Cardiac arrhythmias and overall outcomes with Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia

Heart Rhythm. 2024 Jul 10:S1547-5271(24)02883-2. doi: 10.1016/j.hrthm.2024.07.009. Online ahead of print.

Authors

Stefano H Byer¹, Aravinthasamy Sivamurugan¹, Udhayvir S Grewal², Paari Dominic³

Affiliations

¹ Division of Cardiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
² Division of Hematology, Oncology, and Bone and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
³ Division of Cardiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa. Electronic address: [email protected].

PMID: 38997057
DOI: 10.1016/j.hrthm.2024.07.009

No abstract available

Keywords: Acalabrutinib; Atrial arrhythmias; Cardio-oncology; Chronic lymphocytic leukemia; Ibrutinib; Tyrosine kinase inhibitors; Ventricular arrhythmias.